ImmuPharma plc

IMM.L · LSE
Analyze with AI
12/31/2024
12/31/2023
12/31/2022
12/31/2021
Operating Activities
Net Income-£2-£3-£3-£7
Dep. & Amort.£0£0£0£0
Deferred Tax£0£0£0£0
Stock-Based Comp.£0£0£0£1
Change in WC£0£0-£0£1
Other Non-Cash£0£1£1£0
Operating Cash Flow-£2-£1-£2-£5
Investing Activities
PP&E Inv.-£0£0-£0-£0
Net Acquisitions£0£0£0£0
Inv. Purchases-£0£0£0£0
Inv. Sales/Matur.£1£0£0£0
Other Inv. Act.£0£0£0£0
Investing Cash Flow£1£0-£0-£0
Financing Activities
Debt Repay.£0£0£0-£1
Stock Issued£0£1£2£4
Stock Repurch.£0£0£0£0
Dividends Paid£0£0£0£0
Other Fin. Act.£1-£1-£1-£2
Financing Cash Flow£1£1£2£1
Forex Effect£0-£0-£0-£0
Net Chg. in Cash£0-£0-£1-£4
Supplemental Information
Beg. Cash£0£1£2£6
End Cash£0£0£1£2
Free Cash Flow-£2-£1-£2-£5
ImmuPharma plc (IMM.L) Financial Statements & Key Stats | AlphaPilot